The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
Emcure has launched an awareness campaign to help spread the word about male anemia
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The trial supports the potential for another chemotherapy backbone option that may be paired with encorafenib plus cetuximab in this patient population
Subscribe To Our Newsletter & Stay Updated
